XML 156 R132.htm IDEA: XBRL DOCUMENT v3.26.1
Shareholder' equity - Schedule of Changes in Share Capital, Share Premium and Number of Ordinary Shares and Special Voting Shares (Details)
€ / shares in Units, € in Thousands, $ in Thousands
7 Months Ended 12 Months Ended
Jul. 29, 2025
EUR (€)
€ / shares
shares
Jul. 29, 2025
EUR (€)
€ / shares
shares
Dec. 31, 2025
EUR (€)
shares
Dec. 31, 2024
EUR (€)
shares
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2023
EUR (€)
shares
Dec. 31, 2023
USD ($)
shares
Disclosure of reserves within equity [line items]              
Share issue related cost | € € 1,200            
Treasury price, per share | € / shares € 8.95 € 8.95          
Sale of treasury shares, net | €     € 107,216     € 3,654  
Percentage of ordinary shares outstanding 10.00%            
Total equity attributable to shareholders of the Parent Company              
Disclosure of reserves within equity [line items]              
Sale of treasury shares, net | €     € 107,216     € 3,654  
Equity settled share based payments              
Disclosure of reserves within equity [line items]              
Other long-term employee benefits | $         $ 7,500   $ 7,500
CEO 2022-2024 LTIP              
Disclosure of reserves within equity [line items]              
Number of shares issued, beginning of period (in shares)   588,000 588,000        
Number of shares issued, end of period (in shares)     368,943 588,000 588,000    
CEO IPO Performance Share Units Plan              
Disclosure of reserves within equity [line items]              
Number of shares issued, beginning of period (in shares)   360,000 360,000        
Number of shares issued, end of period (in shares)       360,000 360,000    
Zegna directors              
Disclosure of reserves within equity [line items]              
Number of shares issued, beginning of period (in shares)   430,000 430,000        
Number of shares issued, end of period (in shares)       430,000 430,000    
Senior Management Team              
Disclosure of reserves within equity [line items]              
Number of shares issued, beginning of period (in shares)   609,756 609,756        
Number of shares issued, end of period (in shares)       609,756 609,756    
Zegna non-executive directors              
Disclosure of reserves within equity [line items]              
Number of shares issued, beginning of period (in shares)   78,460 78,460        
Number of shares issued, end of period (in shares)     76,400 78,460 78,460    
Senior Management Team (excluding the CEO)              
Disclosure of reserves within equity [line items]              
Number of shares issued, beginning of period (in shares)   127,000 127,000 30,000 30,000    
Number of shares issued, end of period (in shares)     1,140,546 127,000 127,000 30,000 30,000
Share Capital              
Disclosure of reserves within equity [line items]              
At beginning of period | €   € 9,154 € 9,154 € 9,154      
At end of period | €     9,154 9,154   € 9,154  
Share premium              
Disclosure of reserves within equity [line items]              
At beginning of period | €   € 782,587 782,587 782,587      
At end of period | €     € 782,587 € 782,587   € 782,587  
Outstanding ordinary shares              
Disclosure of reserves within equity [line items]              
Number of shares issued, beginning of period (in shares)   252,503,479 252,503,479 250,310,263 250,310,263    
Ordinary shares assigned under share-based payments (in shares)     1,615,889 2,193,216 2,193,216    
Sale Of treasury shares     14,121,062        
Number of shares issued, end of period (in shares)     268,240,430 252,503,479 252,503,479 250,310,263 250,310,263
Shares issued of transaction cost 26,800,000 26,800,000          
Number of shares outstanding (in shares) 12,700,000 12,700,000          
Ordinary shares held in treasury              
Disclosure of reserves within equity [line items]              
Number of shares issued, beginning of period (in shares)   50,201,247 50,201,247 52,394,463 52,394,463    
Ordinary shares assigned under share-based payments (in shares)     (1,615,889) (2,193,216) (2,193,216)    
Sale Of treasury shares     (14,121,062)        
Number of shares issued, end of period (in shares)     34,464,296 50,201,247 50,201,247 52,394,463 52,394,463
Total ordinary shares              
Disclosure of reserves within equity [line items]              
Number of shares issued, beginning of period (in shares)   302,704,726 302,704,726 302,704,726 302,704,726    
Number of shares issued, end of period (in shares)     302,704,726 302,704,726 302,704,726 302,704,726 302,704,726
Special voting shares              
Disclosure of reserves within equity [line items]              
Number of shares issued, beginning of period (in shares)   154,981,350 154,981,350 154,981,350 154,981,350    
Ordinary shares assigned under share-based payments (in shares)     0        
Sale Of treasury shares     0        
Number of shares issued, end of period (in shares)     154,981,350 154,981,350 154,981,350 154,981,350 154,981,350